So it's pretty clear that the focus of HCT over the last 12 months has been sanitisation specifically in respect to combatting COVID......and as we know COVID is what caused the crash immediately prior to the bull run we've seen in the last 11.5 months.
What's concerning is the HCT share price is now lower than what it was when the crash occurred.......and COVID vaccines are now out which in turn means it's likely the major threat (and business focus of HCT) has now passed.
So where to for HCT now?
Their focus has been combatting COVID
They've missed the opportunity to capitalise on the COVID.....in fact their Market Cap has actually reduced by around 20% from the march 2020 low where most companies on ASX have doubled/tripled from that point.
The product they've been working on is losing value by the day as COVID becomes less of an issue.
I fear there is going to be a significant negative re-rate here as punters realise they don't really have anything to offer in a post COVID world. I'm sure many will argue there is going to be an ongoing COVID threat and that will drive the price up.....but how when all through the pandemic (meaning the threat was real and constant) the price actually dropped significantly)
HCT Price at posting:
7.1¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)